Hong Kong · Delayed Price · Currency is HKD CStone Pharmaceuticals Statistics
Total Valuation
HKG:2616 has a market cap or net worth of HKD 18.38 billion. The enterprise value is 18.05 billion.
| Market Cap | 18.38B |
| Enterprise Value | 18.05B |
Important Dates
The last earnings date was Thursday, August 21, 2025.
| Earnings Date | Aug 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:2616 has 1.46 billion shares outstanding. The number of shares has increased by 1.61% in one year.
| Current Share Class | 1.46B |
| Shares Outstanding | 1.46B |
| Shares Change (YoY) | +1.61% |
| Shares Change (QoQ) | +2.92% |
| Owned by Insiders (%) | 1.51% |
| Owned by Institutions (%) | 13.05% |
| Float | 1.07B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 184.48 |
| PS Ratio | 82.83 |
| PB Ratio | 53.24 |
| P/TBV Ratio | 105.14 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -43.69 |
| EV / Sales | 81.35 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.44, with a Debt / Equity ratio of 1.24.
| Current Ratio | 1.44 |
| Quick Ratio | 1.20 |
| Debt / Equity | 1.24 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -26.86 |
Financial Efficiency
Return on equity (ROE) is -96.36% and return on invested capital (ROIC) is -30.55%.
| Return on Equity (ROE) | -96.36% |
| Return on Assets (ROA) | -16.92% |
| Return on Invested Capital (ROIC) | -30.55% |
| Return on Capital Employed (ROCE) | -65.13% |
| Revenue Per Employee | 2.39M |
| Profits Per Employee | -4.44M |
| Employee Count | 135 |
| Asset Turnover | 0.15 |
| Inventory Turnover | 1.38 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +745.33% in the last 52 weeks. The beta is 0.21, so HKG:2616's price volatility has been lower than the market average.
| Beta (5Y) | 0.21 |
| 52-Week Price Change | +745.33% |
| 50-Day Moving Average | 7.91 |
| 200-Day Moving Average | 4.21 |
| Relative Strength Index (RSI) | 71.09 |
| Average Volume (20 Days) | 32,069,180 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:2616 had revenue of HKD 221.89 million and -413.21 million in losses. Loss per share was -0.32.
| Revenue | 221.89M |
| Gross Profit | -27.03M |
| Operating Income | -404.03M |
| Pretax Income | -413.21M |
| Net Income | -413.21M |
| EBITDA | -389.71M |
| EBIT | -404.03M |
| Loss Per Share | -0.32 |
Balance Sheet
The company has 756.20 million in cash and 428.86 million in debt, giving a net cash position of 327.34 million or 0.22 per share.
| Cash & Cash Equivalents | 756.20M |
| Total Debt | 428.86M |
| Net Cash | 327.34M |
| Net Cash Per Share | 0.22 |
| Equity (Book Value) | 345.22M |
| Book Value Per Share | 0.26 |
| Working Capital | 302.10M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is -12.18%, with operating and profit margins of -182.09% and -186.23%.
| Gross Margin | -12.18% |
| Operating Margin | -182.09% |
| Pretax Margin | -186.23% |
| Profit Margin | -186.23% |
| EBITDA Margin | -175.64% |
| EBIT Margin | -182.09% |
| FCF Margin | n/a |
Dividends & Yields
HKG:2616 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.61% |
| Shareholder Yield | n/a |
| Earnings Yield | -2.25% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |